Cargando…
Perioperative Levosimendan Infusion in Patients With End-Stage Heart Failure Undergoing Left Ventricular Assist Device Implantation
Left ventricular assist device (LVAD) therapy has been instrumental in saving lives of patients with end-stage heart failure (HF). Recent generation devices have short-to-mid-term survival rates close to heart transplantation. Unfortunately, up to 1 in 4 patients develop a life-threatening right-sid...
Autores principales: | Abdelshafy, Mahmoud, Elsherbini, Hagar, Elkoumy, Ahmed, Simpkin, Andrew J., Elzomor, Hesham, Caliskan, Kadir, Soliman, Osama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095918/ https://www.ncbi.nlm.nih.gov/pubmed/35571194 http://dx.doi.org/10.3389/fcvm.2022.888136 |
Ejemplares similares
-
Temporary Right-Ventricular Assist Devices: A Systematic Review
por: Abdelshafy, Mahmoud, et al.
Publicado: (2022) -
Efficacy of levosimendan infusion in patients undergoing a left ventricular assist device implant in a propensity score matched analysis of the EUROMACS registry—the Euro LEVO-LVAD study
por: Abdelshafy, Mahmoud, et al.
Publicado: (2023) -
Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients
por: Elsherbini, Hagar, et al.
Publicado: (2021) -
Correction to: Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients
por: Elsherbini, Hagar, et al.
Publicado: (2021) -
Case report: Transcatheter aortic valve replacement in a large bicuspid anatomy using the XL-Myval 32 mm
por: Elkoumy, Ahmed, et al.
Publicado: (2022)